These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7811843)

  • 1. Pharmacogenetic response to antidepressants in a multicase family with affective disorder.
    O'Reilly RL; Bogue L; Singh SM
    Biol Psychiatry; 1994 Oct; 36(7):467-71. PubMed ID: 7811843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of pharmacogenetics in the treatment of depression and anxiety disorders.
    Schosser A; Kasper S
    Int Clin Psychopharmacol; 2009 Nov; 24(6):277-88. PubMed ID: 19738481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible monoamine oxidase-A inhibitors in resistant major depression.
    Nolen WA; Hoencamp E; Bouvy PF; Haffmans PM
    Clin Neuropharmacol; 1993; 16 Suppl 2():S69-76. PubMed ID: 8313400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antidepressive agents in the elderly].
    de Hooge JK
    Tijdschr Gerontol Geriatr; 1990 Dec; 21(6):259-67. PubMed ID: 1980385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic insights into depression and antidepressant response: does sex matter?
    Pitychoutis PM; Zisaki A; Dalla C; Papadopoulou-Daifoti Z
    Curr Pharm Des; 2010; 16(20):2214-23. PubMed ID: 20459391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of antidepressants.
    Perry PJ; Alexander B
    Prim Care; 1987 Dec; 14(4):773-83. PubMed ID: 3324134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current state and potential of pharmacogenetic studies in the treatment of depression].
    Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to antidepressant drug discovery: beyond monoamines.
    Berton O; Nestler EJ
    Nat Rev Neurosci; 2006 Feb; 7(2):137-51. PubMed ID: 16429123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of antidepressants: clinical pharmacology and therapy.
    Baldessarini RJ
    J Clin Psychiatry; 1989 Apr; 50(4):117-26. PubMed ID: 2647712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
    Reed AL; Happe HK; Petty F; Bylund DB
    Psychopharmacology (Berl); 2008 Apr; 197(3):433-41. PubMed ID: 18180907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.
    Narasimhan S; Lohoff FW
    Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to antidepressant drug design: cytokine-regulated pathways.
    Nishida A; Miyaoka T; Inagaki T; Horiguchi J
    Curr Pharm Des; 2009; 15(14):1683-7. PubMed ID: 19442181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressant drug studies in the elderly.
    Rockwell E; Lam RW; Zisook S
    Psychiatr Clin North Am; 1988 Mar; 11(1):215-33. PubMed ID: 2898134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment resistance in unipolar depression: Is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis?
    Sharma V
    Med Hypotheses; 2006; 67(5):1142-5. PubMed ID: 16797856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.